The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Criticism of the latest Ginkgo study

    I recently labeled G. biloba the “biggest loser in 2009” based on the results of The Ginkgo Evaluation of Memory (GEM) Study that was published in The Journal of the American Medical Association.”

    Now, Mark Blumenthal, founder and executive director of the Austin, Texas-based American Botanical Council, has weighed with his criticism.

    He cited the following flaws:

    • The data were drawn from an earlier study, which was not designed to determine the decline in cognition.
    • About 40% of the participants dropped out of the study over the 6-year duration of the trial.
      • Yet, the study included the dropouts for which no final data were available.
    • Certain cognitive parameters were not monitored until several years after the trial began.
    • The age of the subjects was  advanced — average of 79 years.
      • It’s unknown whether a younger group of ginkgo users would have been more responsive.

    The bottom line

    “This is not the definitive trial on ginkgo,” concluded Mr. Blumenthal.

    1/6/10 20:45 JR

    Leave a Comment

    You must be logged in to post a comment.